SUVEN LIFE SCIENCES LTD. - 530239 - Submission Of Compliance Certificate Under Regulation 40(10) For The Half-Year Ended 30Th September, 2020.
With reference to above subject, please find enclosed Compliance Certificate for the half-year ended 30th September, 2020 issued by the Practicing Company Secretary, under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We request you to take this document on your record. Suven Life Sciences Ltd - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from our RTA dated 19-10-2020 regarding issued duplicate share certificate(s) in lieu of the loss of original share certificate(s) to the following shareholders(s). Name of the Holder Folio No. No. of Shares New Certificate No.(s) Distinctive Nos. From To BODHISHWAR RAI SPL006417 2500 23689 57518601 57521100 2500 23690 115151851 115154350 This is for your information and record. SUVEN LIFE SCIENCES LTD. - 530239 - Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Half-Year Ended 30Th September, 2020
With reference to the above subject, please find enclosed Compliance Certificate for the half-year ended 30th September, 2020 duly signed by the Compliance Officer and authorized representative of the Share Transfer Agent i.e. (KFIN Technologies Private Limited, Hyderabad), under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We request you to take this document on your record. SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 127280 Name of the Signatory :- SHRENIK SONIDesignation :- Company Secretary and Compliance Officer SUVEN LIFE SCIENCES LTD. - 530239 - Shareholding for the Period Ended September 30, 2020
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended September 30, 2020, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by M/s. KFin Technologies Private Limited, Registrar & Transfer Agent of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies Private Limited dated October 06, 2020 are enclosed for your reference. SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window
We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st October, 2020 and the same will remain closed till 48 hours after the declaration of Financial Results for the half year ending 30th September, 2020, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This is for your information and record. SUVEN LIFE SCIENCES LTD. - 530239 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Suven Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here SUVEN LIFE SCIENCES LTD. - 530239 - Reg. 34 (1) Annual Report
This is with reference to our earlier letter dated 24th August, 2020, as per Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the 31st Annual Report for the financial year 2019-20 which includes Directors' Report, Balance Sheet, Statement of Profit & Loss and Cash Flow Statement. The copy of this Annual Report was earlier submitted under shareholders meeting module. We request you to take the same on your record. SUVEN LIFE SCIENCES LTD. - 530239 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
This is with reference to our earlier letter dated 24th August, 2020 regarding the 31st Annual General Meeting (AGM) of the Company held today i.e. Thursday, 17th September, 2020 and the business mentioned in the Notice dated August 11, 2020 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record.